The AMP Molecular Genetic Pathology (MGP) Review Course is a live event held biennially. The 2017 Course was held Thursday, June 1 through Sunday, June 4, 2017, in Bethesda, MD. Visit the Program page for the agenda. The course featured 3.5 days of an intense update and review of molecular diagnostics that is primarily focused on preparation for the Molecular Genetic Pathology (MGP) Subspecialty Certification Exam, as well as other certification exams. Participants had the opportunity to learn directly from recognized experts* in molecular pathology, most of whom hold MGP certification.
The online version of this course is now available for purchase. Go here for more information.
The course provides continuing education credits (CME/CMLE) and SAMs credit. Click here for more information.
The objectives of the AMP MGP Review Course are:
Gregory J. Tsongalis, PhD (Course Director), Dartmouth-Hitchcock Medical Center
* 2017 Course Faculty
John M. Butler, PhD, National Institute of Standards and Technology
Michael B. Datto, MD PhD, Duke University Medical Center
Andrea Ferreira-Gonzalez, PhD, Virginia Commonwealth University/Medical College of Virginia
Charles E. Hill, MD PhD, Emory University
Lawrence Jennings, MD PhD, Lurie Children's Hospital of Chicago
Joel A. Lefferts, PhD, Dartmouth-Hitchcock Medical Center
Elaine Lyon, PhD, University of Utah/ARUP Laboratories
Honey V. Reddi, PhD, The Jackson Laboratory for Genomic Medicine
Ted E. Schutzbank, PhD, St. John Hospital and Medical Center
Gail H. Vance, MD, Indiana University School of Medicine
Barbara Zehnbauer, PhD, Emory University School of Medicine
Please keep checking back here to be the first to enroll in the 2019 course!
DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).